251 related articles for article (PubMed ID: 25654388)
1. Nonalcoholic fatty liver disease: a negative risk factor for colorectal cancer prognosis.
You J; Huang S; Huang GQ; Zhu GQ; Ma RM; Liu WY; Shi KQ; Guo GL; Chen YP; Braddock M; Zheng MH
Medicine (Baltimore); 2015 Feb; 94(5):e479. PubMed ID: 25654388
[TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic fatty liver disease and colorectal cancer survival.
Wu K; Zhai MZ; Weltzien EK; Cespedes Feliciano EM; Meyerhardt JA; Giovannucci E; Caan BJ
Cancer Causes Control; 2019 Feb; 30(2):165-168. PubMed ID: 30443695
[TBL] [Abstract][Full Text] [Related]
3. Influence of non-alcoholic fatty liver disease on the prognosis in patients with colorectal cancer.
Min YW; Yun HS; Chang WI; Kim JY; Kim YH; Son HJ; Kim JJ; Rhee JC; Chang DK
Clin Res Hepatol Gastroenterol; 2012 Feb; 36(1):78-83. PubMed ID: 22133576
[TBL] [Abstract][Full Text] [Related]
4. Association between nonalcoholic fatty liver disease and colorectal cancer: A population-based study.
Wu PH; Chung CH; Wang YH; Hu JM; Chien WC; Cheng YC
Medicine (Baltimore); 2023 May; 102(21):e33867. PubMed ID: 37233422
[TBL] [Abstract][Full Text] [Related]
5. Value of routine test for identifying colorectal cancer from patients with nonalcoholic fatty liver disease.
Yang R; Chen Y; Chen X
BMC Gastroenterol; 2020 Jun; 20(1):180. PubMed ID: 32517710
[TBL] [Abstract][Full Text] [Related]
6. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
[TBL] [Abstract][Full Text] [Related]
7. Association between high fatty liver index and development of colorectal cancer: a nationwide cohort study with 21,592,374 Korean.
Choi YJ; Lee DH; Han KD
Korean J Intern Med; 2020 Nov; 35(6):1354-1363. PubMed ID: 32264657
[TBL] [Abstract][Full Text] [Related]
8. Impact of tumor deposits on the prognosis and chemotherapy efficacy in stage III colorectal cancer patients with different lymph node status: A retrospective cohort study in China.
Li X; An B; Zhao Q; Qi J; Wang W; Zhang D; Li Z; Qin C
Int J Surg; 2018 Aug; 56():188-194. PubMed ID: 29936197
[TBL] [Abstract][Full Text] [Related]
9. Selective Estrogen Receptor Modulator-Associated Nonalcoholic Fatty Liver Disease Improved Survival in Patients With Breast Cancer: A Retrospective Cohort Analysis.
Zheng Q; Xu F; Nie M; Xia W; Qin T; Qin G; An X; Xue C; Peng R; Yuan Z; Shi Y; Wang S
Medicine (Baltimore); 2015 Oct; 94(40):e1718. PubMed ID: 26448028
[TBL] [Abstract][Full Text] [Related]
10. [Non-alcoholic fatty liver disease increases the incidence rate of type 2 diabetes mellitus: a cohort study based on a rural town elderly population of southern Jiangsu].
Shao Y; Xu JY; Lu XL; Chen J; Li T; Wang YT; Shi HT
Zhonghua Gan Zang Bing Za Zhi; 2021 Sep; 29(9):867-872. PubMed ID: 34638206
[No Abstract] [Full Text] [Related]
11. Visceral adiposity index as a predictor of NAFLD: A prospective study with 4-year follow-up.
Xu C; Ma Z; Wang Y; Liu X; Tao L; Zheng D; Guo X; Yang X
Liver Int; 2018 Dec; 38(12):2294-2300. PubMed ID: 30099825
[TBL] [Abstract][Full Text] [Related]
12. The Relationship Between Tamoxifen-associated Nonalcoholic Fatty Liver Disease and the Prognosis of Patients With Early-stage Breast Cancer.
Yan M; Wang J; Xuan Q; Dong T; He J; Zhang Q
Clin Breast Cancer; 2017 Jun; 17(3):195-203. PubMed ID: 28089627
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor cells as an independent prognostic factor in advanced colorectal cancer: a retrospective study in 121 patients.
Wang L; Zhou S; Zhang W; Wang J; Wang M; Hu X; Liu F; Zhang Y; Jiang B; Yuan H
Int J Colorectal Dis; 2019 Apr; 34(4):589-597. PubMed ID: 30627849
[TBL] [Abstract][Full Text] [Related]
14. Elevated tumor-to-liver uptake ratio (TLR) from
Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
[TBL] [Abstract][Full Text] [Related]
15. The relationship of nonalcoholic fatty liver disease and metabolic syndrome for colonoscopy colorectal neoplasm.
Pan S; Hong W; Wu W; Chen Q; Zhao Q; Wu J; Jin Y
Medicine (Baltimore); 2017 Jan; 96(2):e5809. PubMed ID: 28079806
[TBL] [Abstract][Full Text] [Related]
16. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
Wu F; Chen L; Wu W; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancer.
You J; Liu WY; Zhu GQ; Wang OC; Ma RM; Huang GQ; Shi KQ; Guo GL; Braddock M; Zheng MH
Oncotarget; 2015 Aug; 6(23):19880-90. PubMed ID: 26082438
[TBL] [Abstract][Full Text] [Related]
18. [Predictive value of Glasgow prognostic score in patients with colorectal cancer undergoing laparoscopic radical resection].
Cao X; Yu T; Zhao G; Xiao G
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1133-1138. PubMed ID: 27781250
[TBL] [Abstract][Full Text] [Related]
19. The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort study.
Lee JM; Park YM; Yun JS; Ahn YB; Lee KM; Kim DB; Lee JM; Han K; Ko SH
PLoS One; 2020; 15(1):e0226351. PubMed ID: 31978054
[TBL] [Abstract][Full Text] [Related]
20. The association between nonalcoholic fatty liver disease and risk of colorectal adenoma and cancer incident and recurrence: a meta-analysis of observational studies.
Chen J; Bian D; Zang S; Yang Z; Tian G; Luo Y; Yang J; Xu B; Shi J
Expert Rev Gastroenterol Hepatol; 2019 Apr; 13(4):385-395. PubMed ID: 30791768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
